Congshan Jiang

1.6k citations
65 papers · 1.2k indexed · h-index 21
Topics
MicroRNA in disease regulation (19 papers)Cancer-related molecular mechanisms research (11 papers)Immune Response and Inflammation (8 papers)
Partner nations
ChinaUnited StatesSweden

In The Last Decade

Congshan Jiang

63 papers receiving 1.2k citations

Peers

Congshan Jiang
Comparison fields: 5 of 99
  • Molecular Biology 616
  • Cancer Research 326
  • Immunology 274
  • Rheumatology 174
  • Oncology 108
Replace Xiaohong Peng with:
Xiaohong Peng China
Xiongxiong Pan China
Brian Pedersen United States
Xiya Yu China
Ruihua Ma China
Yuru Liu United States
Ken Iseki Japan
Roberto Bomprezzi United States
Zicheng Wang China
Haijing Sun China
Congshan Jiang relative to Xiaohong Peng China Xiaohong Peng's profile →
Citations per field
00.5×7.0×
Xiaohong Peng · 1×
Citations per year

Countries citing papers authored by Congshan Jiang

Since Specialization
Citations

This map shows the geographic impact of Congshan Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Congshan Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Congshan Jiang more than expected).

Fields of papers citing papers by Congshan Jiang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Congshan Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Congshan Jiang. The network helps show where Congshan Jiang may publish in the future.

Co-authorship network of co-authors of Congshan Jiang

This figure shows the co-authorship network connecting the top 25 collaborators of Congshan Jiang. A scholar is included among the top collaborators of Congshan Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Congshan Jiang. Congshan Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 3
3 7
4 6
5 5
6 11
7 13
8 9
9 15
10 30
11 8
12 6
13 24
14 11
15 24
16 44
17 6
18 21
19 47
20 14

About Congshan Jiang

Congshan Jiang is a scholar working on Developmental Neuroscience, Cancer Research and Critical Care and Intensive Care Medicine, having authored 65 papers that have together received 1.2k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (19 papers), Cancer-related molecular mechanisms research (11 papers) and Immune Response and Inflammation (8 papers). The work is most often cited by research in Developmental Neuroscience (91 citations), Cancer Research (326 citations) and Immunology (274 citations). Congshan Jiang has collaborated with scholars based in China, United States and Sweden. Frequent co-authors include Shemin Lu, Liesu Meng, Wenhua Zhu, Jing Xu, Weikun Hou, Yasheng Yan, Thiago Arzua, Xiaowen Bai, Sarah Logan and Jian Sun. Their work appears in journals such as The Journal of Immunology, PLoS ONE and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026